1. Home
  2. AKTX vs UPLD Comparison

AKTX vs UPLD Comparison

Compare AKTX & UPLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Akari Therapeutics plc ADS

AKTX

Akari Therapeutics plc ADS

SELL

Current Price

$7.18

Market Cap

15.4M

Sector

Health Care

ML Signal

SELL

Logo Upland Software Inc.

UPLD

Upland Software Inc.

HOLD

Current Price

$1.50

Market Cap

13.9M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AKTX
UPLD
Founded
N/A
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
13.9M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
AKTX
UPLD
Price
$7.18
$1.50
Analyst Decision
Strong Buy
Buy
Analyst Count
2
2
Target Price
★ $25.50
$12.50
AVG Volume (30 Days)
32.2K
★ 77.0K
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 63.38
EPS
★ N/A
N/A
Revenue
N/A
★ $74,767,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 6.95
52 Week Low
$0.12
$0.50
52 Week High
$29.32
$6.65

Technical Indicators

Market Signals
Indicator
AKTX
UPLD
Relative Strength Index (RSI) 42.25 22.04
Support Level $5.01 $0.62
Resistance Level $9.91 $4.37
Average True Range (ATR) 0.90 0.51
MACD -0.06 -0.27
Stochastic Oscillator 24.25 5.95

Price Performance

Historical Comparison
AKTX
UPLD

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

About UPLD Upland Software Inc.

Upland Software Inc is a software company. It provides cloud-based software applications in three categories: Knowledge Management that provides solutions designed to help organizations capture, organize, and distribute information to employees and customers. Content Lifecycle and Workflow Automation offers solutions that support document management, compliance, and process efficiency across various industries. Digital Marketing solutions that provides tools for audience engagement, campaign management, and content distribution across digital channels. Geographically, the company has operations in the U.S., United Kingdom and Canada, of which United States derives maximum revenue.

Share on Social Networks: